The effect of oestrogens on human calcitonin secretion after calcium infusion in elderly female subjects
- PMID: 7438468
- DOI: 10.1111/j.1365-2265.1980.tb01034.x
The effect of oestrogens on human calcitonin secretion after calcium infusion in elderly female subjects
Abstract
The effect of oestrogen administration (4-6 weeks) on the response of human calcitonin (hCT) secretion to 5 min calcium infusions was studied in ten elderly women. There was no significant difference in mean basal plasma hCT levels before and after oestrogen administration. However, the mean increment in plasma hCT in response to calcium infusion (delta hCT) increased significantly (P < 0.001) from 21.9 +/- 6.6 (mean +/- SE) before treatment, to 79.6 +/- 15.5 ng/l after oestrogen administration. Mean serum calcium levels decreased significantly (P < 0.001) from 2.42 +/- 0.06 before to 2.19 +/- 0.07 mmol/l after oestrogen treatment. Mean plasma immunoreactive PTH (iPTH) levels increased significantly (P < 0.05) from 521 +/- 41 before to 696 +/- 96 ng/l after oestrogen treatment. To exclude out the possibility that the decreased serum calcium level itself might have influenced delta hCT, 1 alpha-hydroxycholecalciferol (1 alpha-OH-D3) was administered with oestrogens. While this resulted in a slight increase in serum calcium level, there was no significant difference in delta hCT in response to calcium infusion following oestrogen treatment alone, and after combination therapy of oestrogen and 1 alpha-OH-D3. The primary action of administered oestrogen may be in stimulating hCT secretion which results in a decrease in plasma calcium concentration and an increase in plasma iPTH level.
Similar articles
-
Comparison of acute effects of 1.25- and 24.25-dihydroxy-vitamin D3 in normal subjects.Acta Endocrinol (Copenh). 1981 Dec;98(4):619-24. doi: 10.1530/acta.0.0980619. Acta Endocrinol (Copenh). 1981. PMID: 6975547
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Comparison of human calcitonin secretion after a 1-minute calcium infusion in young normal and in elderly subjects.Endocrinol Jpn. 1979 Apr;26(2):207-11. doi: 10.1507/endocrj1954.26.207. Endocrinol Jpn. 1979. PMID: 477612
-
Epinephrine is a hypophosphatemic hormone in man. Physiological effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hormone, and calcitonin.J Clin Invest. 1983 Mar;71(3):572-8. doi: 10.1172/jci110802. J Clin Invest. 1983. PMID: 6402521 Free PMC article.
-
1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.Nephron. 1995;71(3):254-83. doi: 10.1159/000188732. Nephron. 1995. PMID: 8569975 Review.
Cited by
-
[Calcitonin and osteoporosis--a critical review of the literature 1980-1989].Klin Wochenschr. 1990 Apr 2;68(7):359-71. doi: 10.1007/BF01650886. Klin Wochenschr. 1990. PMID: 2188043 Review. German.
-
Influence of estrogens on calcitonin secretion.J Endocrinol Invest. 1992 Jan;15(1):59-62. doi: 10.1007/BF03348663. J Endocrinol Invest. 1992. PMID: 1560192 Clinical Trial.
-
Topical administration of 1,25-dihydroxyvitamin D3 for psoriasis: report of five cases.Calcif Tissue Int. 1986 Feb;38(2):119-22. doi: 10.1007/BF02556840. Calcif Tissue Int. 1986. PMID: 3082494
-
Calcitonin metabolism in senile (type II) osteoporosis.Osteoporos Int. 1992 May;2(3):141-5. doi: 10.1007/BF01623821. Osteoporos Int. 1992. PMID: 1627901
-
Calcitonin secretion in children with insulin-dependent diabetes mellitus.Eur J Pediatr. 1991 May;150(7):464-7. doi: 10.1007/BF01958422. Eur J Pediatr. 1991. PMID: 1915495
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous